Swiss stocks - Factors to watch on February 20

ZURICH/GDANSK, Feb 20 (Reuters) - Here are some of the main factors that may affect Swiss stocks on Friday:

NOVARTIS NOVN.S

Swiss drugmaker Novartis will sell its entire 70.68% stake in its listed Indian unit NOIN.BO to a private equity-led consortium for about $159 million, as part of a broader global restructuring.

U.S. President Donald Trump said he met Novartis CEO Vas Narasimhan at the White House on Wednesday, where Narasimhan told him that his company was building 11 U.S. plants as a result of the president's tariff policies.

SIKA SIKA.S

The Swiss construction and automotive chemicals maker expects 2026 sales to rise between 1% and 4% in local currencies, the company said on Friday, and reported better-than-expected annual profit.

SWISS RE SRENH.S

Swiss Re Coporate Solutions will acquire QBE's global trade credit and surety business

SIEGFRIED HOLDING SFZN.S

Full-year revenue rises, but slightly misses analysts' expectations

BB BIOTECH AG BION.S

Full-year results due.

ALLREAL HOLDING ALLN.S

Full-year results due.

ECONOMY

No major Swiss economic data scheduled.

For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6g

FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:
Daily Swiss stock market report in German .SDE
All SMI constituent stocks 0#.SSMI
DJ STOXX index .STOXX
Top 10 STOXX sectors .PGL.STOXXS
Top 10 EUROSTOXX sectors .PGL.STOXXES

Swiss mid-cap index .SSMI
Swiss all-share index .SSHI
Swiss market digest .AD.S
Sector overview CH/SECTOR1
All Swiss news CH
Swiss research news CH-RCH  
All equity news E

SPEED GUIDES:  EQUITY, EQUITY/NEWS1, EUR/EQUITY, SWITZERLAND, REUTERS